Event
Women’s Life Sciences Network – Biotech Act: Funding and Investment Opportunities
Tuesday, May 19, 2026
Event Details
DateTuesday, May 19, 2026
Time5:30 p.m. – 9:00 p.m. CEST
Comet
Place Stéphanie 20
1050 Brussels

Join us in Brussels for our next Women’s Life Sciences Network event on the occasion of the EU Pharmaceutical Law Forum.
Our speakers will discuss the proposed Biotech Act I, focusing on funding and regulatory support opportunities for the European biopharmaceutical industry.
Join our moderated panel discussion with:
- Felicitas Riedl, Director of Innovation and Competitiveness Department, European Investment Bank
- Alexandra Eftimie, Legal and Policy Officer, European Commission
- Kristin Thompson, Director, Merieux Equity Partner
- Valerie Vanhooren, CEO & Co-founder, Ona Therapeutics
The event will include a video address by Stine Bosse, MEP for the Renew Europe group and Vice Chair of the Committee on Public Health in the European Parliament.
Agenda
- Welcome and registration – 5:30 p.m. CEST
- Panel discussion and Q&A – 6:00 p.m. CEST
- Networking reception and canapés – 7:30 p.m. CEST
Stay tuned for more details. All are invited to attend WLSN events.
Related Resources
Capabilities
Suggested News & Insights
A New World Order – Market Access, MFN, and GeopoliticsTuesday, November 10, 2026Sidley & Trinity Capital Life Sciences ReceptionThursday, October 22, 2026Sidley Represents Telix Pharmaceuticals in Its US$1.65 Billion Merger With ITMOctober 5, 2026Most-Favored-Nation Drug Pricing for Medicare Part B Significantly Narrowed in Final RuleOctober 5, 2026Sidley Represents Jiangsu Hengrui in Connection With US$2.6 Billion Licensing Agreement With Novo NordiskOctober 1, 2026Sidley Represents Pyxis Oncology in an up to US$282.6 Million Public OfferingOctober 1, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory